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Structural and Biochemical Characterization of the  
Frequency-interacting RNA Helicase  
 
by 
Jacqueline M. Johnson, Master of Science 
Utah State University, 2016 
 
Major Professor:  Dr. Sean J. Johnson           
Department:  Chemistry and Biochemistry 
 
 RNA is a molecular messenger of the cell, essential to many cellular pathways and 
processes.  In order to maintain functionality, RNA is processed and modified by protein 
complexes such as the exosome and associated proteins.  The exosome-mediated RNA 
processing or degradation both require a Ski-2 like helicase to function.  One such helicase 
is the Frequency-interacting RNA Helicase (FRH), an essential RNA helicase from 
Neurospora Crassa.  FRH is homologous to the Saccharomyces cerevisiae Mtr4 from the 
Ski2-like family of RNA helicases.  Sequence alignments between FRH and Ski2-like 
family helicases predicted FRH to share the helicase core domains and the inserted arch 
domain a characteristic of the Mtr4-like proteins in this protein family.  FRH is also a main 




circadian oscillation is not a shared role across RNA helicases. FRH forms a link between 
two major cellular pathways providing a unique system to study RNA surveillance.  Here 
we present the 3.51Å and 3.25Å crystal structures of FRH which supports structural 
prediction by maintaining the core architecture found in Ski2-like helicases.  These 
similarities are accompanied by significant flexibility of the arch domain and revealed a 
unique homodimer.  Other known Ski2-like helicases have not been observed to form 
dimers and function biologically as monomers.  Furthermore, the initial characterization of 
helicase activity of FRH on a poly-adenylated RNA substrate is presented.  Also explored 










Structural Characterization of FRH  
A Dual Functioning RNA Helicase 
 
by 
Jacqueline M Johnson, Master of Science  
Utah State University, 2016 
 
Major Professor:  Dr. Sean J. Johnson           
Department:  Chemistry and Biochemistry 
 
Cells function through a variety of regulatory pathways intricately communicating 
with one another.  These pathways ensure that cellular functions happen at the appropriate 
times and keep the natural balance within the cell.  When pathways do not communicate 
appropriately, this can lead to disease states and cell death.  Two such connected pathways 
in Neurospora crassa involve the regulation of RNA levels and the circadian rhythms 
essential for these cells to maintain homeostasis.  These pathways are connected by a 
unique helicase called the Frequency-interacting RNA Helicase (FRH), named for its 
discovery with the frequency protein involved in the circadian oscillation of the fungus, N. 
crassa.  All eukaryotes require a way to maintain RNA levels within the cell, in eukaryotes 
the majority of RNA is processed or degraded by the exosome and associated proteins.  
The exosome requires an RNA helicase from the family of Ski2-like helicases to function.  




especially in yeast with the similar protein Mtr4 that is also involved in RNA surveillance.  
Due to this similarity it is predicted that FRH has a similar structure and function to Mtr4.  
However, no other RNA helicase has been shown to be incorporated in the separate 
regulation of circadian rhythms.  The role of FRH in Neurospora is intriguing and provides 
a unique system to study both RNA surveillance and circadian oscillation.  Here we present 
a structural and biochemical characterization of FRH which is similar to the yeast Mtr4 yet 
forms a unique dimer not previously observed.  Discussion for the biological relevance of 
the FRH dimer is presented and future work proposed. 
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BACKGROUND AND SIGNIFICANCE 
 
OVERVIEW 
 RNA is a molecular messenger used by cells to transcribe genetic information from 
DNA, perform catalytic functions, and respond to cellular needs.  RNA is under constant 
cellular surveillance including modification, localization and degradation.  The exosome 
and associated proteins are one of the major RNA modification, surveillance, and 
degradation complexes within the cell (Allmang et al., 1999).  The exosome complex (EC) 
deals with all types of RNA in processes including, stabilizing RNA through 3’ end 
maturation, degrading fragments of RNA resulting from processing or unstable transcripts, 
and quality control (Schneider and Tollervey, 2013) (Chlebowskia et al., 2013).  
Malfunctions in the exosome machinery have been linked to autoimmune and human 
mendelian diseases (Fabre and Badens, 2014) .  In order for the exosome to function, 
activation by a Ski2-like RNA helicase is essential (Jacobs Anderson and Parker, 1998; 
Liang et al., 1996).  In the nucleus, this essential helicase is Mtr4, a 3'-5' RNA helicase 
(Liang et al., 1996).  Mtr4 is found in many eukaryotic species including plants, fungi, and 
humans in various complexes that function to bring RNA to the exosome for processing or 
degradation (Johnson and Jackson, 2013).   The most characterized Mtr4 complex is the 
eukaryotic TRAMP complex used for the processing and degradation of RNA.  In yeast, 




(scMtr4), a poly-A polymerase (Trf4 or Trf5), and a zinc knuckle protein (Air1 or Air2) 
(Vanacova et al., 2005). Air1 or Air2 is thought to recruit RNA substrates to the complex, 
then Trf4 of Trf5 adds a short poly-A tail to the RNA substrate, which can then be unwound 
by the Mtr4 helicase and delivered to the exosome for processing or degradation (Vanacova 
et al., 2005). Another substrate targeting route, uncovered in yeast, involves a specific 
interaction with the arch domain of Mtr4 through an arch interacting motif (AIM) to recruit 
Mtr4 to diverse RNA substrates for modification as well as degradation (Thom et al., 2015).  
Many of these proteins involved in an Mtr4 complex are homologous to human proteins 
and can be found across the eukaryotic kingdom (Johnson and Jackson, 2013).  With a 
variety of model systems to study RNA surveillance available, Neurospora provides a 
unique well-defined model organism.  Herein, the model system used is Neurospora 
crassa, where RNA surveillance is linked to the circadian oscillation pathway through the 
use of an Mtr4 helicase homolog in both pathways (Guo et al., 2009).     
 N. crassa, contains an Mtr4-like protein named the frequency-interacting RNA 
helicase, or FRH (Cheng et al., 2005).  FRH was first identified within the circadian 
oscillation pathway of the fungus and is 55% identical and 73% similar in amino acid 
sequence to the Mtr4 protein observed in S. cerevisiae (Cheng et al., 2005).  Aside from 
being identified as an Mtr4-like RNA helicase, FRH also functions in the circadian 
oscillation pathway, traversing both the cytosol and the nucleus (Guo et al., 2009).  In the 
oscillation pathway, FRH functions as a negative regulator of clock controlled genes 
through repressing the transcription up-regulator white collar complex (WCC) (Cheng et 
al., 2005).  This regulatory role is accomplished through an association with the 




has focused on FRQ interactions to understand the mechanisms of circadian oscillation 
(Guo et al., 2010); however, the FRH helicase has not been studied in the context of RNA 
regulation pathways.  Currently, little enzymatic characterization and no structural 
information has been uncovered to understand the essential role FRH plays in both the 
circadian oscillation and the RNA surveillance pathways.  Presented in this work is a 
literature background followed by the structural and biochemical characterization of FRH.   
RNA 3’END MODIFICATIONS 
RNA provides the cell with a variety of roles from a molecular messenger, to a 
protein code, and catalytic activities.  RNA regulates essential cellular pathways including 
transcription and translation however, most types of RNA need to be processed or modified 
to become active (Allmang et al., 1999).  Common modifications include 5’ capping, 3’ 
end poly-adenylation (poly-A), splicing, trimming, and covalent modifications (Allmang 
et al., 1999; Mitchell, 2014; Viegas et al., 2015).  Modifications of the 3’ end effect 
stability, localization, and functions of RNAs (Mitchell, 2014).  Specifically, the addition 
of a long poly-A tail to the 3’ end has been shown to stabilize RNA transcripts  and 
promotes cellular transport from the nucleus to the cytosol (Viegas et al., 2015).   Usually, 
the long poly-A tail is accompanied by a 5’ cap on the RNA, also to prevent degradation 
(Bernstein and Toth, 2012).  Shortening of the poly-A tail can destabilize the RNA 
transcripts and signal for degradation in the cytosol (Viegas et al., 2015).  Furthermore, 
addition of a short poly-A tail on the 3’ end by the TRAMP complex can be a signal for 
processing or degradation of RNA with the nuclear EC (Figure 1-1) (Vanacova et al., 
2005).  The nuclear exosome and significance of exosome-mediated RNA degradation is 








Figure 1-1. Eukaryotic Exosome-Mediated RNA Degradation. A schematic of the 
nuclear TRAMP complex shown above (Mtr4 core (orange), Mtr4 arch (red), Trf4 (purple), 
Air2 (yellow)) adenylates nuclear RNAs before presenting unwound RNA to the exosome 
















THE EXOSOME FUNCTIONS IN RNA DEGRADATION AND SURVEILLANCE 
 The exosome is one of the main components of RNA degradation and surveillance 
(Jacobs Anderson and Parker, 1998).  Composed of a barrel-like structure formed from two 
stacked rings of RNA binding proteins, the eukaryotic exosome alone has no catalytic 
function (Liu et al., 2006).  The exosome core associates with two ribonucleases to degrade 
ssRNA at the top (Rrp6) (Cristodero et al., 2008) and bottom (Rrp44) (Wang et al., 2007) 
of the core where the RNA is threaded through (Mitchell et al., 1997).  For the nuclear 
exosome complex to receive the ssRNA, the 3'-5' RNA helicase Mtr4 is essential 
(Vanacova et al., 2005) (Figure 1-1).  In the nucleus, the exosome has been shown to 
process precursor RNAs including rRNA, snoRNA, snRNA, and the by-products of these 
reactions (Allmang et al., 1999; Schneider and Tollervey, 2013).  In surveillance, the 
nuclear exosome also receives many cryptic unstable transcripts (CUTs) (Wyers et al., 
2005). The process by which substrates are recruited to the exosome is not well understood. 
In some cases, the associated proteins in the TRAMP complex are required for 
exosome-mediated RNA degradation (Vanacova et al., 2005; Wyers et al., 2005).  The 
TRAMP complex contains an RNA helicase (Mtr4), a poly-A polymerase (Trf4 of Trf5), 
and a zinc knuckle protein (Air1 or Air2) (Vanacova et al., 2005).  Air1 or Air2 are thought 
to recruit RNA substrates to the complex where Trf4 or Trf5 poly-adenylates the RNA 
substrates (Vanacova et al., 2005). Mtr4 then presumably unwinds the secondary structure 
of the RNA providing the EC with a linear substrate for processing or degradation 
(Bernstein et al., 2008).  It has been demonstrated that in the presence of ATP RNA 
substrates with a poly-A tail are the preferred substrate of the RNA helicase Mtr4 




thought to provide necessary momentum by unwinding RNA substrates (Bernstein et al., 
2008) (Figure 1-1). TRAMP is not the only Mtr4-complex involved in processing RNA 
substrates, in fact a different substrate recruitment mechanism for other types of RNAs has 
recently been investigated (Thom et al., 2015).  
This substrate recruitment mechanism utilizes an interaction in the Mtr4 arch 
through an arch interacting motif (AIM) (Thom et al., 2015).  The AIM motif was found 
in the yeast Nop53, a homolog of the human tumor suppressor protein PICT1, as well as 
the yeast Utp18 protein, an essential subunit of the 90S pre-ribosome (Thom et al., 2015).  
Nop53 recruits Mtr4 to pre-ribosomal RNA for processing by the exosome, while Utp18 
recruits Mtr4 to rRNA fragments for exosome-mediated degradation (Thom et al., 2015).  
This recruitment process utilizes the same AIM interaction to recruit Mtr4 to different types 
of substrates through a general mechanism that may be conserved throughout eukaryotes 
with evidence of these proteins in various species (Thom et al., 2015).  Some of these 
species include; Schizosaccharomyces pombe, Kluyveromyces lactis, Neurospora crassa, 
Drosophila melanogaster, Mus musculus, and Homo sapiens (Thom et al., 2015). The AIM 
recruitment pathway is an example of how specific RNA substrates are targeted and 
processed by the exosome and could lead to further understanding of how other RNA 
substrates are identified.  Processing and turnover of RNA is vital to the cell and it is 
important to remember that none of these substrates would reach the nuclear exosome 








Mtr4 is a Ski2-like 3'-5' helicase from the superfamily 2 (SF2) of helicases 
(Fairman-Williams et al., 2010).  Ski2-like helicases include both DNA and RNA helicases 
(Johnson and Jackson, 2013). Specifically, Ski2-like RNA helicases are Ski2, Mtr4, Brr2, 
and S1h1 (Johnson and Jackson, 2013). Classification of these families are based on 
common sequence, structural, and mechanistic features to distinguish them from other 
protein families (Fairman-Williams et al., 2010).  One of these classifying features includes 
the two RecA-like domains shared by superfamily 1 and superfamily 2 helicases (blue and 
yellow Figure 1-2) (Fairman-Williams et al., 2010).  These domains are responsible for 
ATP hydrolysis and nucleotide interactions that form the helicase core (Fairman-Williams 
et al., 2010; Johnson and Jackson, 2013).  The helicase core forms a circular pore with two 
other domains in Ski2-like helicases named the winged helix and ratchet helix (sometimes 
referred to as the helical domain) (green and purple Figure 1-2) (Fairman-Williams et al., 
2010; Johnson and Jackson, 2013).  The winged helix is a small domain while the ratchet 
helix consists of a seven helical bundle first observed in the SF2 DNA helicase Hel308 
structure (Buttner et al., 2007).  The first crystal structure of Saccharomyces cerevisiae 
Mtr4 (scMtr4) was solved in 2010 by the Johnson lab (Figure 1-2A-B, PDB ID 4QU4) 
(Jackson et al., 2010).  The scMtr4 structure revealed a novel arch domain inserted into the 
winged helix observed in other SF2 helicases (Jackson et al., 2010).  The arch domain is 
unique to Ski2 and Mtr4 helicases (Johnson and Jackson, 2013).  In Mtr4, sometimes the 
arch is referred to as the KOW domain due to the first portion of the arch containing a 
KOW motif (Weir et al., 2010).  Two other structures of scMtr4 have since been solved 




stranded RNA substrate (PDB ID: 2XGJ) and another with peptides of TRAMP 
components Air2 and Trf4 (PDB ID: 4U4C).  A similarity between all of the scMtr4 
structures is that the N-terminal region is missing from them possibly due to the region 
predicted to be unstructured through secondary structure analysis (Jones, 1999).  Despite 
the structural information on scMtr4, little is known about the functional role of the arch 
domain.  Investigation of the arch domain has revealed that the arch can bind to structured 
RNAs and may be involved in RNA processing (Taylor et al., 2014).  Another study has 
uncovered the AIM motif found in S. cerevisiae Nop53 and UTP18 used to recruit scMtr4 
to the exosome (Thom et al., 2015).  The AIM motif interaction is only one example of 
Mtr4 in a vast number of protein complexes formed for RNA surveillance across 
eukaryotes.  Mtr4 has been identified in eukaryotic complexes from S. cerevisiae, S. 
pombe, H. sapiens, N. crassa, and possibly others that have been linked to exosome-
mediated degradation (Johnson and Jackson, 2013).  In an effort to elucidate the roles of 
the arch domain and interacting proteins in RNA surveillance and decay, studying these 
Mtr4 homologs and complexes becomes necessary.  One such interesting Mtr4 homolog 
from Neurospora crassa is the Frequency-interacting RNA helicase (FRH) (Cheng et al., 
2005).   
FRH is predicted to be similar to scMtr4 both structurally and functionally.  Based 
on amino acid sequence alignments, FRH is 55% identical and 73% similar to scMtr4 with 
highly dissimilar regions found in the disordered N-termini (Altschul et al., 1997) (Figure 
1-3).  Although there is high similarity in primary sequence between the two helicases, the 
enzymatic activity of FRH has not been characterized.  FRH has also been shown to be 





































Figure 1-2. Mtr4 Domains. A- scMtr4 is shown above in a surface depiction (PDB ID:  
4QU4) (PyMol) with domains colored blue (RecA1), yellow (RecA2), green (winged 
helix), red (arch), and magenta (ratchet helix). B- Sequence of scMtr4 color coded as in 
2A. 
 
  Furthermore, BLAST searches of TRAMP components have revealed Trf4 (36% 
identical) and Air2 homologs present in N. crassa forming evidence for a TRAMP-like 

















but is a vital member of the circadian oscillation within N. crassa where it was first 
identified as a binding partner of the frequency (FRQ) protein homodimer (Cheng et al., 
2005).  These two pathways share FRH as a common factor, however the pathways may 
or may not be functionally linked (Figure 1-4).  N. crassa has been well characterized to 
understand circadian oscillation pathways making FRH an ideal candidate for the 
continued study of an Mtr4-like protein. 
FRH AIDS IN REGULATION OF CIRCADIAN OSCILLATION 
In N. crassa, FRH not only functions as an RNA helicase but also as an essential 
component for circadian oscillation (Cheng et al., 2005) (Figure 1-5).  FRH participates in 
a negative feedback loop of the oscillation pathway through interactions with transcription 
factors White Collar 1 and 2 (WC-1 and WC-2) and Frequency (FRQ) (Shi et al., 2010).  
The positive arm of the circadian clock is regulated by the White collar proteins forming a 
heterodimeric White Collar Complex (WCC) (Shi et al., 2010).  Historically, much of what 
is known about circadian oscillation pathways can be traced back to studies conducted 
using N. crassa as a model system (Aronson et al., 1994).   
In N. crassa, the circadian oscillation begins with the WCC binding to the frq 
promoter to transcribe frq mRNA in the nucleus (Froehlich et al., 2003), which is then 
assumedly transported to the cytosol and translated into FRQ protein.   Immediately 
following translation, the intrinsically disordered FRQ binds to FRH and together they 
form the FRQ/ FRH Complex (FFC) (Hurley et al., 2013). The FFC is then transported to 
the nucleus where it can associate with casein kinase 1 (CK1) (Hurley et al., 2013).  FRQ 
is then phosphorylated on the C-terminus and in regions where FRQ interacts with FRH, 






Figure 1-3. Domain alignments of scMtr4 and FRH. scMtr4 (top) is 1073 amino acids 
long while FRH (bottom) is 1107 amino acids in length.  The core domains are all present 
in FRH based on alignment with the scMtr4 sequence with RecA1(blue), RecA2 (yellow), 
Winged helix (green), Arch (red), and Ratchet helix (purple).  The two N-termini (white) 
are different in length and do not align well. Residue numbers are indicated for the beging 
and end of the sequences as well as the start of each domain. 
 
 
through phosphorylation that breaks up the WCC and frq interaction (Liu and Bell-
Pedersen, 2006). 
Consequently, the WCC leaves the nucleus and frq levels decrease (Froehlich et al., 
2003). Meanwhile, the phosphorylation of FRQ continues on the N-terminus until the 
Skp/Cullin/F-box containing (SCF) complex recognizes the hyper-phosphorylated FRQ 
and ubiquitinates FRQ (Guo et al., 2010; Hurley et al., 2013).  The ubiquitinated FRQ is 
then degraded by the proteasome (Heintzen and Liu, 2007).  The degradation of FRQ 
triggers the release of WC-1 from the FFC allowing the cycle to begin again (Dunlap and 
Loros, 2004).  In total, the cycle takes about 22.5 hours to be completed (Aronson et al., 
1994). 
Furthermore, the WCC and FRH inhibition requires that FRQ be bound to FRH, 
since both proteins contribute to the binding surface for the WCC (Guo et al., 2010).  Also, 
the phosphorylation level of FRQ is an indication for the circadian oscillation period 
(Hurley et al., 2015).  All FRQ proteins are bound to FRH within the cell and FRQ does 





Figure 1-4. Mtr4 Complexes. Mtr4 is in the middle providing RNA to the nuclear 
exosome.  Some of the known complexes formed by Mtr4 homologues are shown by 
double headed arrows if they are known to be involved in RNA surveillance. TRAMP 
(Trf4/Air2/Mtr4pPolyadenylation complex) and homologues have been identified in S. 
cerevisiae, S. pombe, and N. crassa (Johnson and Jackson, 2013).  AIM motif recruitment 
factors and homologues have been identified in S. cerevisiae, S. pombe, H. sapiens, and N. 
crassa (Thom et al., 2015).  Circadian oscillation complexes of Mtr4 homologue FRH have 
been identified in N. crassa with the FRQ and WCC (Cheng et al., 2005).  These complexes 
are represented with a regular arrow because the complexes have not been shown to directly 
interact with the exosome.  
 
Interestingly, the ratio of FRQ to FRH within the FFC complex has been observed to be 























stabilizing FRQ, FRQ can interact with the WCC and inhibit transcription activation of the 
frq gene promoter (Figure 1-5A) turning off the positive feedback loop of circadian 
oscillation (Liu et al., 2003).  The FFC is formed by an interaction between FRQ residues 
774-782 (Guo et al., 2010) and FRH residues 100-150 on the disordered N-terminus of 
FRH (Hurley et al., 2013).  Conversely, when FRH is missing or the FRH-FRQ interaction 
is disrupted, FRQ is hypo-phosphorylated, and rapidly degraded (Guo et al., 2010).  This 
is accompanied by lower levels of WC1 and WC2 indicating that the positive feedback 
loop is also disrupted by the loss of FRH (Guo et al., 2010).  These findings indicate that 
the negative and positive feedback loops rely on one another for balance throughout 
circadian oscillation.  
Conversely, the positive arm of the feedback loop occurs when WCC is not 
inhibited by the FFC.  During positive regulation the WCC binds to the frq promoter and 
recruits the chromatin remodeling complex SWI/SNF (Hurley et al., 2015).  The SWI/SNF 
complex, along with other proteins, removes a nucleosome from the DNA and brings the 
transcription start site into proximity of the frq gene for transcription (Hurley et al., 2015).  
This frq mRNA is then either translated into protein or degraded by FRH to either continue 
or halt the cycle (Guo et al., 2010).  Interestingly, throughout the oscillation period levels 
of FRQ fluctuate while FRH levels remain constant (Cheng et al., 2005).   
FRH is essential to this pathway by providing a chaperone to guide the intrinsically 
denatured FRQ homodimer (Hurley et al., 2013).  Yet, FRH can also transverse from the 
cytosol to the nucleus while the majority of FRQ resides within the nucleus (Cheng et al., 
2005; Hurley et al., 2013).  Although, helicase activity seems unnecessary for FRH to 




maintain rhythmicity (Hurley et al., 2013).  The separation of these activities was 
determined through a series of point mutations to residues specified for helicase function 
in FRH homolog scMtr4 (K208E, E294Q, S326L, and R580P) (Hurley et al., 2013).  
Specifically, the K208E mutation was designed to cripple nucleotide binding, E294Q to 
eliminate ATP hydrolysis, S326L to block unwinding activity, and R580P to stop both 
ATPase and nucleotide binding (Hurley et al., 2013). In each case, rhythmicity was 
observed in N. crassa strains containing each FRH mutant (Hurley et al., 2013). Even if 
helicase activity is not essential for FRH to participate in circadian oscillation, the link 
FRH forms between the circadian oscillation and RNA surveillance pathways may be 
important for maintaining expression levels and cellular availability of some RNAs.  
FRH IS AN ESSENTIAL RNA HELICASE 
 FRH is a unique and essential RNA helicase necessary for growth and the negative 
feedback-loop of daily circadian oscillations (Guo et al., 2010).  Neurospora cell extract 
analysis has enabled the estimation that ~40% of FRH is bound to FRQ at all times leaving 
~60% free FRH within the cell (Cheng et al., 2005). In order to determine the necessity of 
FRH, a quinic acid (QA)-controlled FRH knockdown RNA hairpin was inserted into a wild 
type Neurospora strain (Guo et al., 2010).  The addition of QA allowed for the controlled 
reduction of FRH by ~90% and resulted in arrhythmic strains (Guo et al., 2010).  Levels 
of frq mRNA were also lowered coinciding with lower levels of FRQ protein (Cheng et 
al., 2005).  This decrease in FRH was accompanied by a buildup of cellular frq mRNA 
which is also a substrate for FRH (Guo et al., 2010).    
The accumulation of frq mRNA when FRH is knocked down is an indication that FRH is 




that FRH associates with the catalytic exosome cofactor Rrp4 strengthens the argument 
that FRH is involved in exosome-mediated RNA processing (Figure 1-5B) (Guo et al., 
2009).  A recent article demonstrated how diverse RNA substrates travel to the exosome 
machinery through proteins that recruit scMtr4 to these RNAs.  These yeast recruitment 
factors Nop53 (a homolog of the human tumor suppressor PICT1) and Utp18 part of the 
90S pre-ribosome both contain an arch interaction motif (AIM) to recognize and bind the 
scMtr4 arch domain (Thom et al., 2015).  This AIM motif is found on the N-terminal 
domain and is conserved across various species including the Nop53 and Utp18 N. crassa 
homologs (Thom et al., 2015).   Due to this conservation the N. crassa Nop53 and Utp18 
homologs are predicted to similarly recruit the exosome machinery using the arch domain 
of FRH, as seen in yeast (Thom et al., 2015).  This unique interaction capable of recruiting 
the exosome machinery to specific RNA substrates demonstrates a critical role of the arch.  
Another feature of the AIM interacting region found in scMtr4 is the conserved arginine 
R678 (Jackson et al., 2010) in the arch or KOW region of the scMtr4.  This region is 
recognized by the AIM sequence and the residue is conserved in the FRH arch 
corresponding to residue R712 (Thom et al., 2015). Since the arch domain is unique to 
Mtr4-like helicases (Jackson et al., 2010) this could point to a similar role in different 
species.  Even though the FRH arch maintains secondary structure similarity with Mtr4, 
the primary sequence differs between species with only a 39% identity and 62% similarity 
between primary sequences for the arch region (determined using BLAST (Altschul et al., 
1997)).  These differences may be due to the role of FRH in circadian oscillation and will 








Figure 1-5. Roles of FRH. Circadian Oscillation. A - The WCC promotes the transcription of the frq promoter increasing the levels 
of FRQ protein.  FRQ forms a complex with FRH and CK1 to inhibit the transcriptional regulation of the WCC through phosphorylation.  
FRQ is periodically phosphorylated throughout the day and eventually degraded by the proteasome.  This release of the FFC and WCC 
interaction allows the WCC to start the cycle anew (Hurley et al., 2013).   RNA Surveillance. B – FRH is proposed to participate in 





Maintaining levels of RNA in the cell is critical to cellular stability and the 
prevention of diseases.  Understanding the cellular machinery involved in maintaining 
these RNA levels through exosome-mediated RNA surveillance is still an incomplete 
picture.  Much of the knowledge gap lies within how RNA substrates interact with Mtr4-
like helicases before they are processed by the exosome.  Model helicases such as FRH are 
essential to this process and need to be studied to understand the macromolecular 
interactions involved.  FRH is a unique example of an Mtr4-like helicase due to its 
participation in the circadian oscillation pathway (Cheng et al., 2005).  Although it is 
assumed that FRH and scMtr4 are highly similar this seems to ignore the unique role FRH 
provides N. crassa through the circadian oscillation pathway.  With FRH being the only 
known link between circadian oscillation and RNA surveillance in N. crassa (Guo et al., 
2009), intrinsic differences in scMtr4 and FRH may be present.  Biochemical and structural 
characterization of FRH, the essential Mtr4-homolog found in N. crassa, is presented in 
this work.  Insights into how FRH interacts with RNA through activity assays and structural 
analyses are provided.  Implications of this work include further understanding of a unique 
RNA helicase and consequently expansion of RNA surveillance knowledge.  This unique 
opportunity to study an RNA helicase that links two separate cellular pathways may yield 












 The frequency-interacting RNA helicase (FRH) protein from N. crassa is of 
particular interest because of its dual role as part of the circadian oscillation pathway and 
as an Mtr4-like helicase in RNA surveillance, thereby linking these two important 
regulatory pathways.  Aside from connecting these pathways, little is known about FRH 
structurally and functionally.  It has been proposed that FRH functions similarly to scMtr4, 
in RNA surveillance based on sequence alignments and secondary structure predictions.  
However, while the FRH protein has been shown to play an important role in circadian 
oscillations, the yeast Mtr4 has no such identified function.  This difference highlights a 
unique role for FRH not previously observed in other Mtr4-like helicases.  With this 
knowledge FRH was identified as a unique Mtr4-like helicase to study for this dual role 
and to further the understanding of RNA surveillance.  In this chapter, outlined are the 
methods utilized to express, purify, crystallize, and biochemically analyze FRH. 
 The coding sequence for FRH was first received in a pET_Duet vector containing 
both FRH and FRQ from the Yi Liu lab (University of Texas Southwestern, Dallas).  The 




began work on the project.  FRH contained an N-terminal, six Histidine tag and was cloned 
into a TOPO expression vector using restriction sites KpnI and EcoRI, to be separated from 
FRQ.  Initial expression of recombinant FRH in E.coli BL21 DE3 codon plus cells yielded 
poor solubility in various growth conditions and was thus unsuccessful.  These conditions 
included ZY, LB, and Super broth media, along with different expression times ranging 
from 5-30 hours and temperatures for growth at 16° C, 22° C, and 37° C.  FRH was then 
transferred to an expression vector containing an N-terminal TEV cleavable GST affinity 
tag to improve solubility (SJJ 192).  This strategy was adopted from Lauinger et al. 
supplemental information where soluble expression of FRH was observed (Lauinger et al., 
2014).  A second FRH construct was also made by truncating the first 128 amino acids 
from the N-terminus to aid in crystallization trials (SJJ 193).  Once solubility was achieved, 
a purification protocol was developed.  In short, the purification entails the use of 
Glutathione S-transferase affinity resin (Gold Bio), a Hi-Trap Heparin column (GE 
Healthcare), and size exclusion chromatography (SEC). The developed protocol is 
described in detail in the PROTEIN PURIFICATION section.  Once FRH protein was 
purified to >95%, we began crystallization trials. 
 FRH was first crystallized at 8.8 mg/ml (1:1 drop ratio) in Hampton Research Index 
screen conditions containing 0.2 M Sodium Malonate or 0.2 M Sodium Citrate both at pH 
7.0 with 20% 3350 PEG solution.  These conditions were further optimized by altering the 
pH, precipitant percentage, and concentration of FRH.  Also, utilized was a micro-seeding 
approach to create preformed nucleation sites for the crystals.  The optimization of and 




FRH CONSTRUCTS.  Crystals of FRH yielded two full data sets one of the Full Length 
FRH at 3.5 Å and another of the N-terminally truncated ∆128 FRH at 3.25 Å.  Both of these 
datasets yielded structures that were solved using molecular replacement to obtain phasing 
data and refinement of the data was performed using PHENIX software.  Full data 
collection and specifications are described within this chapter.   
Also observed within the symmetry mates of these structures was a structural dimer 
of FRH.  Analysis of the dimer with surface area interface calculator PISA (Proteins, 
Interfaces, Structures, and Assemblies) revealed that the interaction is predicted to be 
biological, with a perfect complex interface significance score (Krissinel and Henrick, 
2007).  The structure was further analyzed through the use of another interface classifier 
called EPPIC (Evolutionary Protein-Protein Interface Classifier) where the FRH dimer was 
ranked to be biological (Duarte et al., 2012).  The presence of the dimer was also explored 
in various conditions using crosslinking analyses combined with size exclusion 
chromatography.  FRH was further characterized as a helicase in unwinding assays with a 
poly-A RNA substrate.  Published activity assays for scMtr4 helicase activity have 
provided values for which to use as a benchmark comparison for FRH.   Within this chapter 
are the comprehensive methods used to study FRH.  The information provided should 







Full length or the first 128 amino acids N-terminally truncated (∆128) FRH DNA 
sequence from Neurospora crassa were inserted into a GST-pDB PSI E. coli expression 
vector coding for a TEV cleavable, N-terminal, GST tag (Figure 2-1).  The Δ128 construct 
was designed to be similar to the scMtr4 ∆74 construct by removing amino acids predicted 
to be unstructured on the N-terminus through secondary structure prediction software 
(Jones, 1999).  Removing the GST tag through TEV cleavage leaves two extra N-terminal 
residues on the FRH sequence.   
Protein Expression 
FRH protein was recombinantly expressed in an E. coli BL21 (DE3) codon+RIL 
cell line.  Protein expression was induced using an auto-induction protocol and ZY media.  
Traditional IPTG expression with LB media did not produce soluble protein.  Cultures were 
grown under Kanamycin and Chloramphenicol (25 mg antibiotic to 500 ml media) 
antibiotics at 37⁰ C for 5 hours and room temperature for 28 hours to achieve optimum 
protein expression.  Cells were harvested at 10,000 rpm for 30 minutes and stored at -
80⁰ C. 
FRH Protein Purification 
Cells were lysed manually through the use of lysozyme and sonication.  GST-




approximately 95% purity.  TEV cleavage of the GST tag was performed through dialysis 
after the heparin affinity step for approximately 6-8 hours at 4° C.  Lysis and wash buffers 
contained 20 mM NaH2PO4 (pH 7.5), 2 mM beta-mercapto ethanol, 5% glycerol, and 50 
mM salt.  First, the cell pellet (30 g) was re-suspended on ice in five times the volume of 
cell mass in Lysis buffer supplemented with 1X Lysozyme, Pepstatin, Leupeptin, and 
PMSF (GoldBio).  Cells were broken by sonication at 60% power duty cycle 6 for 6 rounds 
of thirty seconds sonicating and thirty seconds resting.  Followed by clarification at 18,000 
rpm for 25 minutes at 4⁰ C.  The soluble fraction was then allowed to batch bind to lysis 
buffer equilibrated GST resin for 2 hours at 4⁰ C.  The flow through was then collected and 
the resin washed with 50 ml of Lysis buffer.  GST elution buffer containing 50 mM Hepes 
(pH 8.0), 10 mM reduced L-Glutathione, 2 mM beta-mercapto ethanol, and 50 mM salt 
was used in elutions. Three 10 ml elutions were performed with a 10-minute incubation 
period between each.  All elutions were then loaded onto a Heparin affinity column.  
Heparin affinity buffers included 50 mM Hepes (pH 7.5), 5% glycerol, 2 mM beta-
mercapto ethanol, and 50 mM or 1 M salt. The column was washed with 25 ml of the 50 
mM salt buffer before fractionation.  Fractions of 2.5 ml volume were collected once the 
salt gradient of 8 column volumes began.  Before the final purification step, FRH fractions 
were pooled for TEV cleavage.  TEV cleavage was performed in dialysis membrane in 500 
ml of TEV buffer containing 50 mM Hepes, 100 mM NaCl, 5% glycerol, and 10 mM beta-
mercapto ethanol.  After one hour of dialysis, a second sample of TEV was added and the 
dialysis buffer exchanged then dialysis was allowed to proceed for 6-8 hours more.   Upon 




50 kDa concentrator at 20,000 rpm and 4⁰ C for intervals of 12 minutes.  Concentrated 
FRH was then loaded onto a 320 ml Superdex column for final purification.  SEC buffer 
contained 50 mM Hepes (pH 7.5), 2mM beta-mercapto ethanol, 5% glycerol, and 100 mM 
salt.  All purification buffers were filtered with a 0.22 µm nitrocellulose filter and kept at 
4⁰ C.  Purification steps were monitored using SDS PAGE gel electrophoresis (Figure 2-
2) and Unicorn UV chromatograms. 
Tips for FRH preps 
 After cell lysis all possible steps need to be performed in the 4⁰ C cold room this 
ensures little degradation throughout the purification.   
 For the lysis of cell pellets larger than 10 grams or greater than 1 L of ZY growth, 
batch binding should be performed in a 250 ml bottle and remain on a shaker at 4⁰ 
C throughout the full 2 hours. 
 For eluting off of GST resin the sample should be agitated and allowed to incubate 
for 10 minutes at 4⁰ C between elutions.  All elutions will be loaded onto the 
Heparin column. 
 For the Heparin elution FRH is unaffected at how long the gradient is, for good 
separation of contaminants the salt gradient can range from 6-10 CV.  Anything 
longer is unnecessary for FRH.  When the chromatogram is visible pool all peak 
fractions for TEV cleavage and dialysis. This is important to do quickly because 










Figure 2-1. Expression Constructs. FRH is recombinantly expressed in a pDB-GST PSI 
vector.  The resulting protein contains a glutathione S-transferase tag (green) linked by a 
TEV cleavage (black) site to the full-length or 128 truncated FRH protein (blue).  The N-
termini to the 128 residue is denoted as unstructured from structural prediction analyses.  
 
Superdex gel above (Figure 2-2 Gel D) is an example of only a 5-hour cleavage 
from before this was known.  It is pertinent to do the full cleavage because 
separation is difficult otherwise and the GST-FRH only appears as a small shoulder 
on the AKTA chromatogram. 
 During concentration of FRH before sizing the TEV within solution may crash out 
at speeds of 1800 rpm.  This does not affect the FRH, if precipitation of TEV occurs 












Figure 2-2. Protein Purification. SDS gels of the purification steps are shown above.  Gel 
A- GST affinity resin step including lanes for the cell pellet, lysate, flow through (FT), 
wash A, wash B, and three 10 ml Glutathione elutions.  Gel B- 5 ml Hi-Trap Heparin 
affinity column showing what was loaded onto the column (load), the FT of the column, 
and samples of fractions from a salt elution gradient.  Gel C- FRH after a complete TEV 
cleavage step run over a 320 ml Superdex column. Gel D- An example of an incomplete 
TEV cleavage step followed by a 320 ml Superdex run.  Both the GST-FL FRH (156k Da) 
and the FL FRH (124 kDa) are clearly visible on the gel. 
 
Activity Assays 
Unwinding activity was determined using a helicase assay developed by Wang et 
al 2008. This assay monitors displaced P32 labeled 16 nt ssRNA from dsRNA utilizing a 5’ 
five amino acid overhang of either Poly-Adenine nucleotides or random nucleotides 




MgCl2, 5% glycerol, 0.01% NP-40 substitute, 2 mM DTT, 1 U/µl Ribolock (Thermo 
Fisher), and protein were combined for a total volume of 120 µl.  ~0.2 nM P32 labeled RNA 
substrate was added and reactions initiated with 1.6 mM ATP/MgCl2.  The reaction was 
incubated at 30⁰ C in a controlled water bath.  Time points were collected at 0, 1, 2, 5, 10, 
20, and 60 minutes while being quenched with an equal volume of 2X stop reaction buffer 
containing 1% SDS, 5 mM EDTA, 20% glycerol, 0.1% bromophenol blue and 0.1% xylene 
cyanol.  Samples were then run on a 15% Native TBE polyacrylamide gel for 110 minutes 
at 100 volts.  Next the gel was wrapped in saran wrap and exposed through use of a 
phosphor screen for 24 hours and then imaged with a STORM phosphor imager utilizing 
Image Quant to analyze the image (Amersham Biosciences).  Time points were plotted in 
Kaleidagraph based on the fraction of unwound RNA over time and the initial rates plotted 
on a Michaelis-Menten plot to determine the Kunwind rate (min
-1) and the K1/2 concentration 
of FRH.  Unwinding activity was performed in triplicate with three separate FRH 
purifications utilized for verification example phosphor image of gel shown in Figure 2-
3A below. 
Crystallization of FRH Constructs 
Optimization from the original Hampton Index conditions of 0.2 M Sodium 
Malonate or 0.2 M Sodium Citrate both at pH 7.0 with 20% 3350 poly ethylene glycol 
(PEG) solution began by altering the PEG and pH.  Two sitting drop hand trays were 
designed to test these (Hampton research), one at pH 6.5-8.0 for 0.2 M Sodium Malonate 










Figure 2-3. Helicase Activity of FRH. A - Helicase substrate of dsRNA and ssRNA 
product depicted next to location on the phosphor screen exposure of a helicase gel 
collected by a STORM scanner. Reaction time points and 95⁰ C boiled control are labeled 
on phosphor image B- Sequence of RNA substrate (R22A) used in helicase assays.  
Substrate contains a 5 poly-A tail as a 3’ overhang.  
 
from PEG 14%- 24% in 2% increments.  From these trays crystals only grew at room 
temperature in the Sodium Citrate conditions containing 24% PEG 3350 at pH 5.5 or 6.0. 
The crystals were small at this point but, the pH 6.0 were just large enough to loop and test 
with the Johnson lab home source.  These crystals diffracted between 7-8 Å resolution with 
a distinct pattern indicative of a protein crystal (Figure 2-4A-B). At this stage many of the 
crystals grew on the plastic pedestal within the sitting drop tray and were broken when 
trying to loop so hanging drop trays were utilized to prevent this.  Optimization continued 
with the 0.2 M Sodium Citrate pH 6.0 conditions because it yielded diffracting protein 
crystals.  3350 PEG values were narrowed to 18-22% in a 1:1 protein: well drop ratio to 
95⁰ C 
T (min) = 0  2   5  10  20 
16 bp RNA 
              R16 (top strand) = 3’CGCAGAAAUGCCACGA 5’  






produce crystals that diffracted between 4-5 Å at the Johnson lab home source (Figure 2-
4C-D).  Crystals were also grown using microseeding dilutions and using a 2:2:1 protein: 
well: seed ratio these crystals.  The microseeded crystals in the 100,000 and 1,000,000 seed 
range produced crystals that diffracted around 4 Å at SSRL.  The two data sets collected 
utilized microseeds of 1,000,000 for the 3.5 Å for the FL FRH crystal and 1,000,000 for 
the 3.25 Å Δ128 FRH crystal. Crystallization was shown to occur between 3 to 7 mg/ml 
final concentration of FRH in the drop however, higher and lower values were not tested. 
Data Collection, Structure Determination, and Model Refinement 
Crystallographic data were collected from 30 to 3.5 Å for the full length FRH 
construct and 30 to 3.25 Å for the Δ128 FRH construct at the Stanford Synchrotron 
Radiation Laboratory (SSRL) on beamline 7-1. Data were processed using HKL2000 
(Otwinowski and Minor, 1997). The FRH crystals belong to space group P3121 with cell 
dimensions and angles listed in the table below.  Both crystals contain one molecule in the 
asymmetric unit supported by Matthews coefficient =2.6 Å³/Dalton; 52.69% solvent 
(Kantardjieff and Rupp, 2003; Weichenberger and Rupp, 2014). Initial phases were defined 
using molecular replacement from homolog scMtr4 (PDB ID 4U4C) for the first FRH 
structure and for the second structure the 3.5 Å FRH structure was utilized. Refinement 
with the PHENIX software included using rigid body and grouping B factor settings while 
restricting TLS parameters to maintain visible secondary structure.  Optimization of XYZ 
coordinates and stereochemistry or sidechains was used to account for the positioning of 



























Figure 2-4. FRH Crystallization and Diffraction. A- FRH crystals from the first round 
of optimization in 0.2 M Sodium Citrate pH 6.0 and 24% 3350 PEG.  B- First diffraction 
pattern resulting from crystal in 8A of FRH at 7-8 Å resolution. C- Depicts an optimized 
FRH crystal in 0.2 M Sodium Citrate pH 6.0, 20% 3350 PEG, containing a 1,000,000 







B factors for the sidechains before each refinement to maintain a lower final B factor after 
refinement.  Final refinement statistics are displayed for each crystal in Table 2-1 below. 
Crosslinking 
 
Assay was performed in (sizing buffer) 50 mM Hepes (pH 7.5), 100 mM salt, 5% 
glycerol, 2 mM beta-mercapto ethanol, and 0.01% Triton-X 100.  0.01-0.05% 
Glutaraldehyde crosslinking reagent was added to 0.2-1.0 µM FRH.  Crosslinking was 
performed at 30⁰ C for 5-15 minutes with the reaction quenched with 10 µl 1M Tris pH 8 
and a 1:4 ratio of 4X SDS sample dye and boiled for 5 minutes before SDS-PAGE analysis 
(Figure 2-5). 
Size Exclusion Chromatography 
 1 mg/ml FRH samples were prepared using FRH sizing buffer in 100 µL volume 
with or without 10 µL of 2.3% glutaraldehyde (high percentage to ensure crosslinking).  
Control and crosslinked samples were incubated at 37° C for 15 minutes and quenched 
with 20 µL of 1 M Tris pH 8.0.   Samples were then desalted using an equilibrated 0.5 ml 
Zeba spin column (Thermo Fischer). Desalting was performed at 4° C and 8,000 rpm. 
Samples were then filtered using a 0.22 µM spin filter (Thermo Scientific) at 8,000 rpm 
for 30 seconds. 10 µl samples of purified FL FRH or crosslinked FRH were loaded onto 
an equilibrated 3 ml Superdex 200 Increase 5/150 GL (GE Healthcare) and run at 0.15  





Table 2-1. Data Collection and Refinement. 3.5 Å FL FRH and 3.25 Å Δ128 FRH 







Data Collection and Refinement   
    Beamline SSRL 7-1 SSRL 7-1 
 Space group P3121 P3121 
 Cell dimensions   
  a, b, c (Å) 118.5, 118.5, 179.6 118.9, 118.9, 181.6 
  α, β, γ (°) 90.0, 90.0, 120.0 90.0, 90.0, 120.0 
 Resolution (Å) 30 – 3.51 (3.64 - 3.51) 30 – 3.25 (3.39 - 3.25) 
    No. of reflections   
       unique 18761 24009 
       total 352123 513013 
 I/σ(I) 22.7 (1.0) 74.8 (1.1) 
    Completeness (%) 99.9 (100) 100 (99.8) 
    Redundancy 21.2 (21.3) 21.0 (20.8) 
    CC¹/₂ 0.99 (0.308) 1.0 (0.305) 
    Rwork/Rfree  0.2478/0.2998 0.3014/0.3345 
   Total no. protein atoms 7198 7202 
   B factors (Å2) 164.6 120.6 
   RMSD bonds (Å) 0.011 0.007 
   RMSD angles (°) 1.75 1.497 
   Ramachandran Favored (%) 88.6 88.8 



















Figure 2-5. Glutaraldehyde Crosslinking of FRH. Group 1 lanes are FRH (1.6 µM, 4 
µM, 8 µM) without Glutaraldehyde. Group 2 are a BSA without and with reagent. Groups 
3, 4, 5 are FRH in 0.2 M NA Citrate pH 6, 50 mM Hepes pH 7.5, and a 50/50 mixture of 
both buffers respectively.  FRH was kept at the same concentrations as the negative 
controls.  2.3% Glutaraldehyde was added and allowed to react for 5 minutes before 
quenching. 
 
Dimer Interface Validation 
Both Proteins, Interfaces, Structures, and Assemblies (PISA) (Krissinel and 
Henrick, 2007) and interface prediction software Evolutionary Protein-Protein Interface 
Classifier (EPPIC) (Duarte et al., 2012) independently determined the surface area between 
dimers to be 2444.9 Å² per monomer.  The interaction includes 14 hydrogen bonds and 4 
salt bridges.  Structural validation for the interaction being biologically relevant is the 
perfect 1.0 Complex Formation Significance Score (PISA) (Krissinel and Henrick, 2007). 
CONCLUDING REMARKS 
The comprehensive methods presented in Chapter 2 are for FRH expression, 
purification, crystallization, and activity assays.  The structural analyses performed are 







FRH work should be repeatable.  Within Chapter 3, ANALYSIS OF FRH STRUCTURAL 








ANALYSIS OF FRH STRUCTURAL AND BIOCHEMICAL RESULTS 
 
INTRODUCTION 
 FRH is an essential RNA helicase, necessary for the circadian oscillation and RNA 
surveillance pathways within N. crassa (Guo et al., 2009).  FRH has been extensively 
studied for its chaperone role in the circadian oscillation pathway of N. crassa, which does 
not seem to be dependent upon helicase activity (Hurley et al., 2013).  However, FRH has 
been demonstrated to be an essential helicase necessary for cell viability through a possible 
role in RNA surveillance (Cheng et al., 2005) .  This dual functionality in two essential 
pathways has not been observed for other known RNA helicases, making the link FRH 
forms between the circadian oscillation pathway and RNA surveillance in N. crassa 
intriguing.  Due to this unique role and the need to further understand exosome-mediated 
RNA surveillance, FRH was pursued.  Structural and biochemical characterization are 
presented in this work to start to answer how FRH functions as a unique Ski2-like RNA 
helicase.                                                                                                                                                                                                                                                  
RESULTS 
FRH Purification and Expression 
 In brief, a purification strategy was developed for FRH.  First, FRH was 
recombinantly expressed in E. coli through utilizing a GST expression vector.  Following 
cell lysis, FRH was extracted through the use of GST and Heparin affinity resins.  A TEV 




performed as a final purification step.  FRH was then concentrated and stored in a 25% 
glycerol containing buffer at -80⁰ C until use.  These methods are discussed in detail in the 
Chapter 2. 
FRH Structural Analysis 
Structurally, FRH has been predicted to be highly similar to scMtr4.  This has been 
the speculation due to sequence identity (53%) and similarity (73%) from NCBI BLAST 
(Altschul et al., 1997).  Even though these two proteins are predicted to be similar, no 
structural information has been determined for FRH to elucidate the actual structure.  In 
this work, the solved crystal structure of FRH is presented.  The structure is accompanied 
by an explanation of how phasing was addressed, electron density fitted, and how the data 
was refined.   
FRH was first collected at 3.5 Å resolution with a P3121 space group using the 
SSRL beamline 7-1.  Crystallization was performed with the hanging drop vapor diffusion 
method.  Conditions included; 11.1 mg/ml FRH, 0.2 M Sodium Citrate pH 6.0, 20% 3350 
Poly-Ethylene Glycol (PEG), and a 1: 1,000,000 crystal seed from a previous hand tray in 
a 1:1:1 ratio.  Molecular replacement was used with a scMtr4 structure (Falk et al., 2014) 
(PDB ID: 4U4C) to define the phasing for the dataset.  Interestingly, the arch domain of 
FRH had a different conformation than the available scMtr4 structures.  This 
conformational difference meant the entire FRH arch domain had to be built using 
secondary structure elements visible within the density.  One of the major challenges of 
working with this resolution was determining where the fist portion of the arch was.  One 




allowing for a fist to be modeled in.  A unique morphology of a Ski2-like helicase became 
visible as each portion of the arch domain was modeled in (Figure 3-1).  Not only were the 
arch domain and fist regions in a drastically different conformation than previously 
observed in scMtr4 structures but, a structural dimer within the crystal was also present.  
All other Mtr4-like and Ski2-like helicases have been observed to be monomeric thus far, 
making the FRH dimer interesting.  Another crystal structure of FRH, excluding the first 
128 residues was later solved to 3.25 Å and displayed the same dimeric structure.  These 
findings have elicited deliberations on this dimer for biological relevance which will follow 
within this chapter in the section titled FRH DIMER.  Structural analyses of domain 
movement and comparison to other Ski2-like helicases will follow.  
FRH Maintains Ski2 Core Domains  
FRH is a Ski2-like helicase maintaining the two RecA domains within the helicase 
core RecA1 (blue) and RecA2 (yellow), a winged helix (green), and the ratchet helix 
(magenta) (Figure 3-1) (Johnson and Jackson, 2013). The FRH core (colored) was aligned 
to the winged helix domain of the available scMtr4 structures (grey) for comparison of the 
core domains (Figure 3-2).  RMS values, generated in PyMol (Table 3-1), indicate that the 
FRH core domains adopt a conformation most similar to the “TRAMP-like” scMtr4 
structure (Falk et al., 2014) (PDB ID: 4U4C).  This similarity to a partial complex of 
scMtr4, may be due to the cores in the dimeric FRH packing together.  However, domain 
motion may be shifted in comparison because they are from different organisms.  From 
these alignments, one can conclude that the overall core domains seen in Ski2-like 


















Figure 3-1. Crystal Structure of FRH. Surface representation of the FRH crystal 
structure generated using PyMol.  Domains colored blue for RecA 1, yellow for RecA 2, 
green for the winged helix, red for the arch, and magenta for the Ratchet helix domain.  
The KOW or fist region of the arch is also labeled. 
  
similar, differences in the arch domain are visible.  The arch domain is a unique 
characteristic of Ski2-like helicases being inserted into the winged helix domain (Jackson 
et al., 2010).  The arch protrudes from the middle of the winged helix (domain 3) out of 
the helicase core creating a domain 3a (Johnson and Jackson, 2013).  The known scMtr4 
arch domains are compared structurally to the FRH arch domain in the section titled ARCH 
DOMAIN.  Similarity in the core domains of FRH and scMtr4 suggest a similarity in 
RecA 1 
RecA 2 







activity that will be discussed in the CHARACTERIZATION OF HELICASE ACTIVITY 
section.  However, the noticeable difference in the arch domains will be discussed first. 
Arch Domain 
 The arch domain is an accessory domain inserted within the core winged helix 
domain 3 in Ski2-like helicases (Jackson et al., 2010).  The arch domain contains two 
helical arms ascending and descending from the globular fist region that is positioned 
above the helical core.  The arch appears to be somewhat flexible with the focal point of 
movement spanning from the winged helix and the connection between the helical arms 
and fist (Johnson and Jackson, 2013). A comparison of the conformation seen for the 
scMtr4 arch (Taylor et al., 2014)(PDB ID:  4QU4) and the FRH arch are shown below 
demonstrating a 12.1 Å shift in the helical arms to be further over the helical core and a 
33.7 Å “flip of the wrist” to move the fist higher above the core, than previously observed 
with scMtr4 (Figure 3-3).  These conformational changes display a different overall shape 
allowed within the arch domain of FRH.  The difference in the FRH arch may be due to 
crystallographic packing and/or differences in protein interactions.  Furthermore, this 
difference in conformation could indicate a role for the arch domain in FRH not present 
for scMtr4.  In fact, the interaction between the WCC and FRH arch domain is necessary 
for the circadian oscillation pathway (Shi et al., 2010).  The responsible residue for this 
interaction has been identified as a conserved arginine within the arch domain (R806) (Shi 
et al., 2010).  This demonstrated role for the arch in N. crassa agrees with an arch 
recognition mechanism to recruit Mtr4-like helicases.  A similar recruitment model has 











Figure 3-2. Winged Helix Alignments. Core alignments using the winged helix between 
the FRH core (colored) and three scMtr4 structures.  scMtr4 structures include 4QU4 no 
substrate bound (apo), 2XGJ containing a 5 nucleotide poly-adenine substrate, and 4U4C 
containing peptides of TRAMP components. 
 
Table 3-1. RMS values (PyMol) of FRH compared to Mtr4 core domains. RMS 
measured in Å, when the winged helix domain is aligned as shown in Figure 3-2. 
 
Domain 4QU4 2XGJ 4U4C 
RecA1 3.217 1.088 0.880 
RecA2 3.322 2.663 1.824 
Ratchet Helix 5.002 1.557 1.388 
 
 
(Thom et al., 2015).  Despite these findings, the overall role and function of the arch in 
RNA surveillance is still under investigation.  Currently, the FRH arch has had little 










Previously, the scMtr4 fist has been shown to bind structured hypo-modified tRNA 
however, not to bind single stranded poly-A RNA (Johnson and Jackson, 2013).  The 
binding of structured RNA indicates that structured RNA substrates can interact with the 
arch.  Due to their structural similarity and the conservation of the KOW motif, (structured 
RNA binding motif) it is predicted that FRH also uses the fist region to bind structured 
RNAs.  This binding may be used as a guide for the RNA into the helicase core however, 
further investigation is needed to determine this.  The fist has also been demonstrated to 
promote RNA substrate unwinding in scMtr4 (Taylor et al., 2014).  This finding supports 
a model where the arch is guiding the RNA into the core domains of the helicase.  The fist 
has also been shown to act as a recognition site for chaperone proteins to recruit Mtr4 to 
the exosome machinery for the processing of specific RNA substrates (Thom et al., 2015).  
Due to structural similarities and the conservation of key residues, these roles are likely to 
transverse to the N. crassa system as well. 
Characterization of Helicase Activity 
In order to characterize FRH helicase activity, assays were performed as for scMtr4 
(Jackson et al., 2010; Taylor et al., 2014; Wang et al., 2008).  Previously, domain 4 residues 
in the scMtr4 ratchet helix have been shown to be involved in unwinding rates of RNA 
substrates (Taylor et al., 2014).  The authors pointed out the conservation of residues along 



















Figure 3-3. Arch Alignment. FRH arch (red) and winged helix (green) aligned to the 
corresponding scMtr4 (PyMol) (PDB ID:  4QU4) region (grey).  This alignment 
demonstrates the conformational differences observed between the crystal structures.  
 
residue R1063) to control the preference for a poly-A RNA substrate (Taylor et al., 2014).  
This observation may indicate that FRH prefers the same type of poly-A RNA substrates.  
To begin to answer this question, FRH activity has been characterized with the same RNA 
substrate containing a poly-A tail used for scMtr4.  The RNA unwinding results are shown 
in Figure 3-4.  The FRH Kunwind max is 0.562 +/- (0.094) min
-1 and the K1/2 766.06 +/- 
252.79 nM.  These results are still initial values with an R2 of only 0.976 and a large error 
bar at the 1200 nM FRH concentration.  Further assays will need to be conducted to address 
these disparities.  The reported values for scMtr4 Kunwind max is 0.59 +/- 0.05 min
-1 and the 
K1/2 252 +/- 60 nM (Taylor et al., 2014).  While the Kunwind max of FRH and scMtr4 are 
fairly similar there is a large discrepancy of the K1/2 values.  The difference in the K1/2 may 






to the conservation between their catalytic regions (Johnson and Jackson, 2013).  Based on 
the similarity of the Kunwind max values, FRH is a comparable helicase to scMtr4.  Although 
characterization of helicase activity is an important comparative measure, the helicase 
assay is not designed to observe how the RNA substrate is recognized by the helicase.   
The processes of how RNA substrates are recognized by FRH and scMtr4 are still 
not fully understood.   As discussed previously, other proteins such as Nop53, Utp18, 
(Thom et al., 2015) and the TRAMP complex can recruit scMtr4 to RNA substrates for 
exosome-mediated degradation (Vanacova et al., 2005).  The ability of the arch domain to 
bind structured RNAs has implicated the arch to participate in substrate recognition (Taylor 
et al., 2014).  Further preference of these RNAs to be poly-adenylated is regulated by the 
ratchet helix however, this polyadenylation is not necessary for unwinding to occur (Taylor 
et al., 2014).  This ambiguity in RNA substrates makes determination of an overall 
recognition model difficult.  It is reasonable to speculate that processing of different RNA 
substrates are based on the presence of different recruitment proteins.   
FRH Dimer  
            FRH stands out as a lone example of a dimeric Ski2-like RNA helicase.  All other 
RNA helicases within this family are represented as monomers (Fairman-Williams et al., 
2010).  Dimeric RNA helicases are not prevalent in the literature with only several 
examples available.  One example is, MjDEAD a DEAD-box helicase from 
Methanococcus jannaschii that forms an N-terminal dimeric association through beta sheet 
secondary structure (Story et al., 2001).  Another DEAD-box helicase HERA from 






Figure 3-4. Helicase Assay. A- Helicase substrate of dsRNA and ssRNA product depicted 
next to location on the phosphor screen exposure of a helicase gel collected by a STORM 
scanner. Reaction time points and 95⁰ C boiled control are labeled on phosphor image. B- 
Initial Michaelis-Menten cure from FL FRH with R22A substrate depicted above with error 
bars from triplicate data collection.  
 
MDA5 forms a C-terminal dimer (Berke and Modis, 2012) and UAP56/URH49 together 
from an N-terminal dimer through alpha helical secondary structure all from Homo sapiens 
(Zhao et al., 2004).  Despite these examples, only the MjDEAD protein forms a dimer 
through a beta sheet extension similarly to FRH however, none have a dimer interface 
highly similar to the FRH dimer. This lack of a similar dimeric interface makes comparison 
and validation of the dimer FRH difficult.  Specifically, the FRH dimer is located on the 
N-terminus through a beta sheet secondary structure continuation and amino acid 





N-terminal region of dimeric FRH to the monomeric scMtr4, it is apparent that scMtr4 has 
a secondary structure difference preventing the association seen in FRH.  The scMtr4 N-
terminus forms a long beta sheet hairpin (β hairpin) connected to the RecA1 core domain, 
while FRH has a disordered N-terminus.  The function of this β hairpin structure is 
currently unknown aside from preventing the same dimer interface seen in the FRH crystal 
structure.  PISA analysis has indicated the dimer is formed through 14 hydrogen bonds and 
four salt bridges formed from sidechain residues (Table 3-2).  The dimer interface (Figure 
3-5) forms a surface area of 2444.9 Å² per subunit (Krissinel and Henrick, 2007).  When 
analyses under surface interface validation software (Duarte et al., 2012; Krissinel and 
Henrick, 2007) (PISA & EPPIC) the FRH dimer is ranked as likely to be biological.  From 
PISA, the dimer has a perfect complex significance score of 1 and EPPIC ranked the 
interaction to be biologically relevant.  Results from EPPIC classifier are listed in Table 3-
3.  Both of these analyses predict that the dimer is biological and not an artifact of the 
crystallographic conditions.  
PISA and EPPIC utilize unique algorithms to assess the validity of an observed 
dimer interface. PISA has an 80-90% success rate in identifying biological complexes 
(Krissinel and Henrick, 2007) and EPPIC has a success rate of 88% as tested against a 
PDB-wide search (Baskaran et al., 2014). PISA utilizes a surface area approach to 
eliminate interactions that do not contain enough interaction area between proteins and also 
predicts bonds between interfaces (Krissinel and Henrick, 2007). EPPIC utilizes a different 
approach relying on evolutionary data from proven biological interfaces to predict 
sequence entropy within homologous protein sequences (Duarte et al., 2012). The EPPIC 




present in a crystal structure (Duarte et al., 2012). Core residues are broken into two classes 
95% or greater buried residues are used for core geometry prediction and 70% or greater 
are used for evolutionary prediction and rim residues are the remainder (Duarte et al., 
2012). The agreement between the PISA and EPPIC analyses provides strong structural 
support for the validity of the observed FRH dimer.  
            Despite the structural evidence suggesting an FRH dimer, biochemical support for 
this conclusion is lacking.  Previous studies have shown FLAG tagged FRH is unable to 
pulldown V5 tagged FRH (Hurley et al., 2013).  However, multimeric states are observed 
by gel filtration when FRH is in complex with FRQ (Lauinger et al., 2014).  Further 
validating the significance of the observable crystallographic dimer was pursued through 
crosslinking assays combined with size exclusion chromatography.  Glutaraldehyde 
chemical crosslinking was utilized in various conditions where dimeric molecular weight 
was observed.  The dimeric molecular weight was observed in concentration of 50 mM and 
100 mM NaCl (Figure 3-6).  The 50mM concentration was utilized to demonstrate 
conditions that are most likely below the NaCl concentration in the cell while the 100 mM 
concentration was utilized to demonstrate a higher concentration.  Crosslinked and 
untreated FRH samples were also ran on a size exclusion column to determine size elution 
profiles.  The goal of this experiment was to determine if untreated FRH ran at the dimeric 
FRH size by comparing treated and untreated FRH samples.  However, the effectiveness 
of the crosslinking reagent made isolation of a dimeric FRH difficult to obtain, due to the 
formation of other multimeric species.  This result may indicate multimeric species are also 




optimization of crosslinking conditions to isolate a pure dimeric FRH sample can be 
pursued to utilize this technique in the future.  Determining the biological significance of 
the observed FRH dimer structure may be necessary to determine roles performed by FRH.   
Despite the convincing structural argument for the FRH dimer, other Ski2-like 
helicases have been observed to be monomeric.  In fact, the well characterized scMtr4 has 
always been observed to be monomeric.  In an effort to determine any significant 
differences that would allow formation of a dimer in FRH but not scMtr4, the topology of 
the two N-termini were compared (Figure 3-7). Amino acid sequence alignments of the N-
terminus along with secondary structure indicate one more β-sheet present on the N-
terminus of scMtr4 that is not present in FRH or the RecA1 domain (Figure 3-7A).  The 
first β-sheet observed in FRH corresponds to the second in scMtr4 and is much shorter 
containing only five residues in comparison to thirteen residues.  The first two β-sheets in 
scMtr4 have been previously identified as an N-terminal β-hairpin (Weir et al., 2010).  This 
β-hairpin folds across both RecA1 and RecA2 domains on the scMtr4 core providing 
stability and appears to be unique to scMtr4 (Weir et al., 2010).  In the absence of the N-
terminal β-hairpin, FRH appears to provide stability by packing a second FRH molecule 
through the extension of the β-sheets in the RecA1 domains of both cores (Figure 3-7B). 
CONCLUSION 
 Within this chapter the FRH structure and activity have been analyzed and 
compared to scMtr4.  FRH is shown to maintain the core domains present in Ski2-like 








Figure 3-5. FRH Dimer Interface. FRH dimer displayed with two-fold symmetry seen in 
the crystal structure.  Also displayed is the monomer in surface representation with the 
interface residues (red) and non-interface residues (grey). 
 
compared to the scMtr4 arch demonstrating a different conformation observed in FRH.  
Helicase assays with the poly-A R22A substrate indicate that FRH has comparable activity 
to scMtr4.  Also, the unique dimer observed in the crystal structure is still lacking biological 
significance and cannot be concluded from the work presented here.  However, why scMtr4 
cannot form this dimeric structure was investigated through the conflicting topology 
observed in the N-terminus.  Future work to explore the FRH dimer and complete 
characterization of helicase activity are discussed in the Summary and Future Directives 




Table 3-2. PISA Interface Results.  
 
Number of Residues 
Interface        72     7.8% 
Surface      869   93.7% 
Total      927 100.0% 
 
Solvent Accessible Area (Å) 
Interface    2444.9     5.4% 
Total 455520.4 100.0% 
 
Hydrogen Bonding Residues  
Structure 1 Structure 2 Distance (Å) 
LYS 168 VAL 142 2.77 
GLN 150 ASN 146 3.12 
HIS 149 ILE 147 2.79 
ILE 147 HIS 149 2.99 
LYS 376 ASP 156 2.98 
ARG 657 GLU 381 3.06 
ASN 883 ASN 883 3.63 
VAL 142 LYS 168 2.77 
ASN 146 GLN 150 3.12 
ILE 147 HIS 149 2.79 
ASP 156 LYS 376 2.98 
GLU 381 ARG 657 3.06 
ASN 883 ASN 883 3.63 
 
Salt Bridge Residues 
Structure 1 Structure 2 Distance (Å) 
LYS 376 ASP 156 2.98 
ARG 657 GLU 381 3.06 
ASP 156 LYS 376 2.98 







Table 3-3. EPPIC Classifier Results of Evolutionary Core and Rim Residues. Core 
residues of evolutionary importance are utilized to identify residues likely to be conserved 
throughout homologues. Entropy is defined in EPPIC as the probability of an amino acid 
to be at a certain position in aligned sequences (Duarte et al., 2012). 
 
Core Evolution Residues >70% 
Residue % Core Entropy 
SER 144 71 1.38 
ASN 146 71 0.27 
ILE 147 71 0.00 
HIS 149 88 0.00 
VAL 151 77 0.08 
ALA 186 82 1.86 
HIS 346 72 0.00 
GLU 674 75 0.08 
LEU 687 78 0.00 
SER 718 97 2.16 
SER 720 73 1.02 
VAL 722 93 2.35 
LEU 867 72 0.00 
PRO 871 79 0.46 
SER 875 81 0.81 
PRO 876 94 0.58 
VAL 879 99 1.45 
 
EPPIC Totals and Scores  
Total Core Total Rim Core-Rim Score Core-Surface Score Result 






Figure 3-6. Optimization of Crosslinking Conditions for FRH.  5 µM FRH was 
crosslinked with either 0.02% or 0.05% glutaraldehyde at 30°C for 5 or 10 minutes with 
50 mM of 100 mM NaCl. The utilization of two different salt concentrations indicates the 
crosslinking conditions show a salt dependent formation. The monomeric band (124kDa) 














Figure 3-7. Comparison of the scMtr4 and FRH N-termini and Topology. A- Amino 
acid alignment of scMtr4 and FRH N-termini with β-sheet secondary structure indicated 
by arrows.  B- Topology diagram of β-sheets seen in scMtr4 RecA1 domain monomer 










SUMMARY AND FUTURE DIRECTIVES 
 
 
FRH is a unique RNA helicase involved in two distinct cellular pathways.  In this 
work a clear recombinant expression and purification protocol was outlined for studying 
FRH (Chapter 2).  With these protocols, future studies can reliably replicate the presented 
work.  Furthermore, crystallization conditions leading to the first structural information for 
FRH were presented at 3.5 Å with FL FRH and 3.25 Å resolution with Δ128 FRH (Chapter 
2). The surprising structural dimer observed in the crystal structure still lacks conclusive 
biological evidence however, demonstrating dimeric formation through crosslinking, size 
exclusion chromatography, and structural analyses heavily point towards this conclusion 
(Chapter 3).  The presented crystallization conditions can be followed to consistently 
crystallize FRH and further be used as a starting point for the crystallization of other FRH 
constructs.  Characterization of helicase activity was performed with a poly-A RNA 
substrate previously used to characterize scMtr4.  The initial results indicate that FRH is 
comparable to scMtr4 with this R22A substrate (Chapter 3).  This work provides a starting 
point for future analyses proposed within this chapter. 
BIOLOGICAL SIGNIFICANCE OF FRH DIMER 
Elucidating the biological significance of the observed FRH dimer have proven 
difficult.  Size exclusion chromatography has indicated multimeric FRH species are 
observed when FRQ is present (Lauinger et al., 2014). This technique was further used on 




untreated and crosslinked FRH.  Although initial runs proved inconclusive, optimization 
of crosslinking condition should allow for the comparison of these samples in the future.  
A comparison of elution profiles would determine if untreated FRH runs as a monomer or 
dimer on a size exclusion column.  Future constructs of FRH lacking the arch domain may 
also help elucidate more information on dimeric formation and significance.  A crystal 
structure of an archless FRH construct could yield evidence for how the two cores are 
packing and if the arch is required to stabilize this interaction.  An archless construct has 
been created and soluble expression verified for these studies.  Explanation of the archless 
FRH design will follow. 
ARCHLESS FRH DESIGN 
 The archless FRH vector was designed to be similar to the characterized archless 
scMtr4 construct.  Removal of the arch was performed using a Gibson Assembly technique 
to remove the arch containing region and to insert residues from the DNA helicase Hel308 
helicase (Figure 4-1A).  Hel308 does not contain an arch domain.  Instead, Hel308 contains 
a small loop (Buttner et al., 2007).  This Hel308 loop region was previously used in the 
archless scMtr4 design to maintain core domain geometry and consequently, was used in 
the FRH archless design as well.  Soluble expression of the GST tagged archless FRH 
protein (123kDa) is observed in both IPTG and auto-induction growth media (Figure 4-
1B). 
CONTINUED CHARACTERIZATION OF HELICASE ACTIVITY 
For helicase activity, this work focused on the comparison of FRH to scMtr4 on a 






































Figure 4-1. Archless FRH Design and Solubility. A- Schematic design for removal of 
the arch domain from FRH to create the archless FRH sequence with the insertion of the 
Hel308 loop (ELST). Sequences are color coded for N-terminus (grey), RecA1 (purple), 
RecA2 (yellow), winged helix (green), arch (red), Hel308 loop (light blue), and ratchet 
helix (pink). B- Soluble expression of GST tagged archless FRH (123kDa) seen in the 







the TRAMP complex found in S. cerevisiae (Taylor et al., 2014).  TRAMP homologs have 
been identified in N. crassa yet, have not been studied.  Since TRAMP in the N. crassa 
system has not been characterized, determining a preference for poly-A substrates on FRH 
would strengthen the model of FRH in a TRAMP complex and RNA surveillance.  An 
archless FRH construct could be used in these helicase assays as well, to determine if 
differences exist between scMtr4 and FRH proteins.  Studies with scMtr4 have indicated 
that an archless scMtr4 construct elicits a slow growth phenotype (Taylor et al., 2014).  
This archless scMtr4 was also observed to still unwind poly-A RNA substrates 
preferentially (Taylor et al., 2014).  Performing helicase assays with the archless FRH 
could further the comparison between these two helicases. 
CRYSTALLIZATION OF FRH CONSTRUCTS AND COMPLEXES  
 Structural characterization of FRH complexes has not been performed.  Elucidating 
structural information about FRH complexes in both the circadian oscillation pathway and 
RNA surveillance pose to have significant impact in the understanding of both.  Another 
question is of the biological significance of the observed FRH dimer, structures of FRH 
constructs and complexes could further elucidate the biological validity of this dimer.  To 
start, an easily obtained structure should be of the archless FRH construct.   An archless 
FRH structure could demonstrate if the arch domain is necessary for the dimer to form.  
The known FRH conditions can be used as a starting point to undergo crystallization trials 
of the archless FRH.  If these conditions do not yield crystals broader conditions will be 
pursued.   
Also, the current crystal structures of FRH are considered Apo structures without 




analogues could further be helpful in observing substrate interactions within the helicase 
core.  Currently, the RNA-bound scMtr4 structure (2XGJ) provides information on 
interactions between RNA and the ratchet helix domain (Weir et al., 2010).  Despite this, 
the RNA present is not long enough to visualize potential interactions between the other 
domains where another crystal structure may elucidate these interactions.  Other structures 
of interest include complexes of FRH. 
 The FRQ protein minimal binding region to bind FRH has been identified in the 
literature (Guo et al., 2010).  Exactly where this interaction occurs on FRH though has not 
been fully characterized but has been narrowed down to residues 100-150 on the N-termini 
(Hurley et al., 2013).  Crystallization trials of FRH and the FRQ minimal binding region 
could determine the molecular nature of this interaction further and possibly shed light on 
the dimeric FRH observed in the crystal structure.  Trials with an FRQ peptide can be 
performed in two ways.  One strategy can attempt to soak the peptide into previously 
formed FRH crystals.  Another approach can be to co-crystallize the peptide and FRH 
protein together.  Both of these strategies have been attempted yielding no results however, 
preliminary results at this are not enough to say these strategies have been exhausted.  Both 
strategies should be pursued to obtain a structure of the FRH-FRQ interaction.  Many of 
the proposed crystallization trials have potential to impact the understanding of FRH in 
both the circadian oscillation and RNA surveillance pathways.  FRH provides a model 
protein that has proved to be easy to work with and shown to repeatedly crystallize.  
SUMMARY 
 This work has focused on the structural and biochemical understanding of the 




previously observed for other Ski2-like helicases.  Although the structural analyses of the 
dimer are convincing, the biological significance of the dimer is still lacking conclusive 
results.  In addition, a full purification protocol and initial activity assays are demonstrated 
for the future study of FRH and related constructs.  The characterization of FRH helicase 
activity has the potential to be completed with various RNA substrates by following the 
protocols laid out in this work.  Overall, FRH is a unique Mtr4-like helicase with roles in 
two essential biological pathways in N. crassa (Guo et al., 2009).  The potential impact of 
understanding FRH interactions can further both the knowledge of RNA surveillance and 
circadian oscillation pathways.  Only further analysis of this intriguing RNA helicase will 
answer how FRH has linked the circadian oscillation and RNA surveillance pathways of 
N. crassa.  The proposed work with the archless FRH construct, continued helicase assays, 
and the pursuit of FRH complex crystal structures will help to answer how FRH links 
circadian oscillation and RNA surveillance.  The presented study of the unique RNA 
helicase FRH provides a foundation for future efforts to address the biological significance 
of the FRH dimer, to characterize the helicase activity of FRH, and to determine the 
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N. cra    1   MD--DLFEVFEEQPRAQKKRKASPDVEMADGAAAAAPVANAAAAVTHPQAQAAPAPQKDN 
S. cer    1   MDSTDLFDVFEETP-----------VELPTDSNGEKNADTNVGDTPDHTQDKKHGLEEEK 
                
 
N. cra   58   IDNNDNNNNNTTTSAVQPTIPNGDAAAAADDVQSPQSPHGLGDNKRRKKTDEAEPIMTDA 
S. cer   50   EEHEENNSENKKIKSNKSKTEDKNKKVVV-------------------------PVLADS 
               ...                          
 
N. cra  118   FQTAESREVTGAQGFAPTE------GESIVLSHNIQHQVALPPDLDYEYIPLSEHKPPAE 
S. cer   85   FEQEASREVDASKGLTNSETLQVEQDGKVRLSHQVRHQVALPP--NYDYTPIAEHKRVNE 
            
 
N. cra  172   PARTYSFKLDPFQALSVASIEREESVLVSAHTSAGKTVVAEYAIAQCLKKNQRVIYTSPI 
S. cer  143   -ARTYPFTLDPFQDTAISCIDRGESVLVSAHTSAGKTVVAEYAIAQSLKNKQRVIYTSPI 
                
 
N. cra  232   KALSNQKYRDFQAEFGDVGLMTGDVTINPTASCLVMTTEILRSMLYRGSEIMREVAWVVF 
S. cer  202   KALSNQKYRELLAEFGDVGLMTGDITINPDAGCLVMTTEILRSMLYRGSEVMREVAWVIF 
             
 
N. cra  292   DEIHYMRDKIRGVVWEETIILLPDKVRYVFLSATIPNAFQFAEWIAKIHRQACHVVYTDF 
S. cer  262   DEVHYMRDKERGVVWEETIILLPDKVRYVFLSATIPNAMEFAEWICKIHSQPCHIVYTNF 
                 
 
N. cra  352   RPTPLQNYFFPAGGKGILLIVDEKGNFKENNFNQAMAMIEEKKGTDSNDWSAKQKGKGKN 
S. cer  322   RPTPLQHYLFPAHGDGIYLVVDEKSTFREENFQKAMASISNQIGDDPNS----TDSRGKK 
                 
 
N. cra  412   KKTNKGGEA-ADEKADIAKIIKMILKKNFQPVIVFNFSKRECEQMALASSSMKFNAPDEE 
S. cer  378   GQTYKGGSAKGDAKGDIYKIVKMIWKKKYNPVIVFSFSKRDCEELALKMSKLDFNSDDEK 
                 
 
N. cra  471   NMVNKVFENALASLSEDDKNLPQISNILPLLRKGIGVHHSGLLPILKETIEILFQEGLIK 
S. cer  438   EALTKIFNNAIALLPETDRELPQIKHILPLLRRGIGIHHSGLLPILKEVIEILFQEGFLK 
                 
 
N. cra  531   VLFATETFSIGLNMPARTVVFTQVTKWDGQQRRPLTSSEYIQMAGRAGRRGLDDRGIVIM 
S. cer  498   VLFATETFSIGLNMPAKTVVFTSVRKWDGQQFRWVSGGEYIQMSGRAGRRGLDDRGIVIM 
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Appendix Figure A1. Secondary Structure Alignment of FRH and scMtr4. Neurospora crassa 
(N. cra) FRH primary sequence is aligned to the Saccharomyces cerevisiae (S. cer) sequence of 
scMtr4.  Secondary structure is depicted for helices (cylinders), beta-sheets (arrows), and random 
coils (lines) from the solved FRH structure and scMtr4 (PDB ID: 4QU4) with unbuilt regions 
 
 
N. cra  591   MVDDKLEPETARAIVVGNQDKLNSAFHLGYNMVLNLLRIEAISPEYMLERCFFQFQNAAS 
S. cer  558   MIDEKMEPQVAKGMVKGQADRLDSAFHLGYNMILNLMRVEGISPEFMLEHSFFQFQNVIS 
 
N. cra  651   VPQLERELISLQQERDAIIIPDESIVKDYYGVRQQLEEYNKDMVFVIQHPQNCLGFFQEG 
S. cer  618   VPVMEKKLAELKKDFDGIEVEDEENVKEYHEIEQAIKGYREDVRQVVTHPANALSFLQPG 
                 
 
N. cra  711   RLIHIKSPSGVDYGWGVLIKHIQRQTPKNGQPPYPEQESYVLDVLLK---VSGDFNPKTR 
S. cer  678   RLVEISVNGKDNYGWGAVVDFAKRINKRNPSAVYTDHESYIVNVVVNTMYIDSPVNLLKP 
                  
 
N. cra  768   GEGPMPEGIMPAGKDSKNARWEVVPCLLNCLRALGQLRVFLPKRLESADEKDGVGKAVDE 
S. cer  738   FNPTLPEGIRPAEEGEKSIC-AVIPITLDSIKSIGNLRLYMPKDIRASGQKETVGKSLRE 
                  
 
N. cra  828   ISRRFPDGIPILDPMENMGINDDSFKKLLRKIEVLESRLVANPLHNSPLLVELWNQYSLK 
S. cer  797   VNRRFPDGIPVLDPVKNMKIEDEDFLKLMKKIDVLNTKLSSNPLTNSMRLEELYGKYSRK 
                 
 
N. cra  888   MQLGEQIKEKKKAIARAHSVAQLDELKSRKRVLRRLGFINDAEVVQMKARVACEISSTEG 
S. cer  857   HDLHEDMKQLKRKISESQAVIQLDDLRRRKRVLRRLGFCTPNDIIELKGRVACEISS--G 
                  
 
N. cra  948   HELLLAELLFNRFFNELSPEICACILSCFIFDEKI-ETQALKEELAKPFREIQAQARIIA 
S. cer  915   DELLLTELIFNGNFNELKPEQAAALLSCFAFQERCKEAPRLKPELAEPLKAMREIAAKIA 
                  
 
N. cra 1007   KVSAESKLDVNEDEYVQSLKWQLMETVLAWAQGRPFSEICKMTNVYEGSLIRLFRRLEEL 
S. cer  975   KIMKDSKIEVVEKDYVESFRHELMEVVYEWCRGATFTQICKMTDVYEGSLIRMFKRLEEL 
                 
 
N. cra 1067   LRQMAEAARVMGSEELKDKFELSLSKIRRDIVSFNSLYL   1106 
S. cer 1034   VKELVDVANTIGNSSLKEKMEAVLKLIHRDIVSAGSLYL   1073 
                 
 
N-terminal  Domain 1 RecA1 Domain 2 RecA2 Domain 3 Winged helix  

















































indicated (dashed lines).  Helices and beta sheets are numbered according to the scMtr4 structure 
for comparison.  Sequence conservation for eleven species of Mtr4 and eight species of Ski2 
helicases is indicated for strictly conserved residues (red) and similar residues (yellow) as published 
in Jackson et al. 2010. 
 
 
Figure A2. Domain alignments of scMtr4 and FRH. scMtr4 (top) is 1073 amino acids 
long while FRH (bottom) is 1106 amino acids in length.  The core domains are all present 
in FRH based on alignment with the scMtr4 sequence with RecA1(blue), RecA2 (yellow), 
Winged helix (green), Arch (red), and Ratchet helix (purple).  The two N-termini (white) 
are different in length and do not align well. Residue numbers are indicated for the beging 
and end of the sequences as well as the start of each domain. 
 







Domain FRH Residues scMtr4 Residues 
N-terminal 1-157 1-126 
Domain 1 158-352 127-319 
Domain 2 353-609 320-574 
Domain 3 610-644, 905-944 575-607, 874-910 
Domain 3a 645-904 608-873 
  Arms 645-697, 855-904 607-664, 818-873 
  Fist 698-854 665-817 













Pairwise alignment comparing scMtr4 and FRH with identity and similarity of sequences calculated 
using NCBI protein BLAST 
 
Table A3. RMS Values of Domains 
Domain  RMS align Cα Atoms RMS current Cα Atoms 
Domain 1 0.535 157 2.84 188 
Domain 2 0.955 187 1.618 224 
Domain 3 0.946 53 2.214 72 
Arch arms 2.750 98 3.167 104 
Arch fist 1.507 113 2.943 147 
Domain 4 1.236 104 3.14 143 
 
RMS values calculated in PyMol using the align command which aligns two selections and 
calculates a refined RMS value for the c-alpha carbons.  The RMS_cur command was then used to 
compare all of the c-alpha atoms in the previously performed alignment.  The c-alpha atoms for 
each calculation are included. 
  
Region Sequence Identity (%) Sequence Similarity (%) 
N-terminal 40% 60% 
Domain 1 81% 87% 
Domain 2 63% 77% 
Domain 3 before arch 77%  96% 
Domain 3a 39% 62% 
   Arms ascending 42% 69% 
   Fist 37% 59% 
   Arms descending 44% 68% 
Domain 3 after arch 58% 80% 
Domain 4 51% 69% 
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